Progress in Neuro-Psychopharmacology and Biological Psychiatry
Volume 64, 4 January 2016, Pages 231-236
Review articleThe neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury
Under a Creative Commons license
open access
Abbreviations
ADHD
attention hyperactive disorder
AKT
protein kinase B
AMPA
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Bcl-2
B-cell lymphoma 2
BDNF
brain derived neurotrophic factor
Css
Steady state plasma concentration
D1
type 1 dopamine receptor
D2
type 2 dopamine receptor
DAT
dopamine transporter
FDA
Food and Drug Administration
IV
intravenous
MRI
magnetic resonance imaging
NAT
norepinephrine transporter
NMDA
N-methyl-D-aspartate
OGD
oxygen glucose deprivation
PET
positron emission tomography
PI3K
phosphoinositol 3 kinase
PV
parvalbumin
RHSC
rat hippocampal slice cultures
SERT
serotonin transporter
SST
somatostatin
TBI
traumatic brain injury
USP
United States Pharmacopeia
UTD
untreated
VMAT
vesicular monoamine transporter
Keywords
Methamphetamine
Neuroportection
Stroke
Traumatic brain injury
Cited by (0)
Copyright © 2015 The Authors. Published by Elsevier Inc.